Singapore, July 21 -- 10x Genomics, Inc., a leader in single cell and spatial biology, and the A*STAR Genome Institute of Singapore (A*STAR GIS), have announced a research collaboration for the Target Inference from Spatialomics & Histology Using Multimodal AI & Phenotypes (TISHUMAP) project.

This initiative will leverage 10x Genomics' Xenium platform and advanced artificial intelligence (AI) to analyse thousands of tissue samples with the goal of accelerating drug target discovery and enabling precision medicine for cancer and inflammatory diseases.

As part of the TISHUMAP study, A*STAR GIS and 10x Genomics will analyse up to 2,500 formalin-fixed paraffin-embedded (FFPE) clinical tissue samples, including those from gastric, liver and ...